These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19081526)

  • 1. A prospective study of risk factors and historical trends in metronidazole failure for Clostridium difficile infection.
    Hu MY; Maroo S; Kyne L; Cloud J; Tummala S; Katchar K; Dreisbach V; Noddin L; Kelly CP
    Clin Gastroenterol Hepatol; 2008 Dec; 6(12):1354-60. PubMed ID: 19081526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clostridium difficile strain NAP-1 is not associated with severe disease in a nonepidemic setting.
    Cloud J; Noddin L; Pressman A; Hu M; Kelly C
    Clin Gastroenterol Hepatol; 2009 Aug; 7(8):868-873.e2. PubMed ID: 19465153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective observational study comparing three different treatment regimes in patients with Clostridium difficile infection.
    Wenisch JM; Schmid D; Kuo HW; Allerberger F; Michl V; Tesik P; Tucek G; Laferl H; Wenisch C
    Antimicrob Agents Chemother; 2012 Apr; 56(4):1974-8. PubMed ID: 22252830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining the vulnerable period for re-establishment of Clostridium difficile colonization after treatment of C. difficile infection with oral vancomycin or metronidazole.
    Abujamel T; Cadnum JL; Jury LA; Sunkesula VC; Kundrapu S; Jump RL; Stintzi AC; Donskey CJ
    PLoS One; 2013; 8(10):e76269. PubMed ID: 24098459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Markers of intestinal inflammation, not bacterial burden, correlate with clinical outcomes in Clostridium difficile infection.
    El Feghaly RE; Stauber JL; Deych E; Gonzalez C; Tarr PI; Haslam DB
    Clin Infect Dis; 2013 Jun; 56(12):1713-21. PubMed ID: 23487367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin.
    Al-Nassir WN; Sethi AK; Nerandzic MM; Bobulsky GS; Jump RL; Donskey CJ
    Clin Infect Dis; 2008 Jul; 47(1):56-62. PubMed ID: 18491964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-Stratified Treatment Response Rates in Hospitalized Patients with Clostridium difficile Infection Treated with Metronidazole.
    Pham VP; Luce AM; Ruppelt SC; Wei W; Aitken SL; Musick WL; Roux RK; Garey KW
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6113-6. PubMed ID: 26195522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Metronidazole Monotherapy versus Vancomycin Monotherapy or Combination Therapy in Patients with Clostridium difficile Infection: A Systematic Review and Meta-Analysis.
    Li R; Lu L; Lin Y; Wang M; Liu X
    PLoS One; 2015; 10(10):e0137252. PubMed ID: 26444424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NAP1 strain type predicts outcomes from Clostridium difficile infection.
    See I; Mu Y; Cohen J; Beldavs ZG; Winston LG; Dumyati G; Holzbauer S; Dunn J; Farley MM; Lyons C; Johnston H; Phipps E; Perlmutter R; Anderson L; Gerding DN; Lessa FC
    Clin Infect Dis; 2014 May; 58(10):1394-400. PubMed ID: 24604900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of association of outcomes with treatment duration and microbiologic susceptibility data in Clostridium difficile infections in a non-NAP1/BI/027 setting.
    Venugopal AA; Riederer K; Patel SM; Szpunar S; Jahamy H; Valenti S; Shemes SP; Khatib R; Johnson LB
    Scand J Infect Dis; 2012 Apr; 44(4):243-9. PubMed ID: 22077148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does Addition of Intravenous Metronidazole to Oral Vancomycin Improve Outcomes in Clostridioides difficile Infection?
    Wang Y; Schluger A; Li J; Gomez-Simmonds A; Salmasian H; Freedberg DE
    Clin Infect Dis; 2020 Dec; 71(9):2414-2420. PubMed ID: 31714955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of skin contamination and environmental shedding of Clostridium difficile during and after treatment of C. difficile infection.
    Sethi AK; Al-Nassir WN; Nerandzic MM; Bobulsky GS; Donskey CJ
    Infect Control Hosp Epidemiol; 2010 Jan; 31(1):21-7. PubMed ID: 19929371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of highly discriminatory fingerprinting to analyze clusters of Clostridium difficile infection cases due to epidemic ribotype 027 strains.
    Fawley WN; Freeman J; Smith C; Harmanus C; van den Berg RJ; Kuijper EJ; Wilcox MH
    J Clin Microbiol; 2008 Mar; 46(3):954-60. PubMed ID: 18216211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridium difficile bacteremia, Taiwan.
    Lee NY; Huang YT; Hsueh PR; Ko WC
    Emerg Infect Dis; 2010 Aug; 16(8):1204-10. PubMed ID: 20678312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clostridium difficile infection in older adults: a review and update on its management.
    Kee VR
    Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent epidemiology of Clostridium difficile infection during hematopoietic stem cell transplantation.
    Chopra T; Chandrasekar P; Salimnia H; Heilbrun LK; Smith D; Alangaden GJ
    Clin Transplant; 2011; 25(1):E82-7. PubMed ID: 20973823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter-based study on epidemiology, antibiotic susceptibility and risk factors of toxigenic Clostridium difficile in hospitalized patients in southwestern Iran.
    Sedigh Ebrahim-Saraie H; Heidari H; Amanati A; Bazargani A; Alireza Taghavi S; Nikokar I; Kalantar K; Motamedifar M
    Infez Med; 2018 Dec; 26(4):308-315. PubMed ID: 30555133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of Clostridium difficile NAP1 in Latin America.
    Quesada-Gómez C; Rodríguez C; Gamboa-Coronado Mdel M; Rodríguez-Cavallini E; Du T; Mulvey MR; Villalobos-Zúñiga M; Boza-Cordero R
    J Clin Microbiol; 2010 Feb; 48(2):669-70. PubMed ID: 19940046
    [No Abstract]   [Full Text] [Related]  

  • 19. The Addition of Intravenous Metronidazole to Oral Vancomycin is Associated With Improved Mortality in Critically Ill Patients With Clostridium difficile Infection.
    Rokas KE; Johnson JW; Beardsley JR; Ohl CA; Luther VP; Williamson JC
    Clin Infect Dis; 2015 Sep; 61(6):934-41. PubMed ID: 26024909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for Clostridioides difficile infection and colonization among patients admitted to an intensive care unit in Shanghai, China.
    Cui Y; Dong D; Zhang L; Wang D; Jiang C; Ni Q; Wang C; Mao E; Peng Y
    BMC Infect Dis; 2019 Nov; 19(1):961. PubMed ID: 31711425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.